Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T14:42:36.127Z.
Calculation as of: 2026-10-06T14:42:36.127Z.
Quote observation: 2026-10-06T14:38:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f6adff8253f4c85dc5eb0f5c76b7f284768243a99251a0912c87940a98678e1d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Lifeward Ltd.
Market Cap
$10.15M
EV/EBIT Ratio
N/A
| NAME | MARKET CAP | EV/EBIT RATIO |
|---|---|---|
| Lifeward Ltd. (LFWD) | $10.15M | N/A |
| MetaVia Inc. (MTVA)vs › | $10.15M | N/A |
| Caring Brands, Inc. (CABR)vs › | $10.09M | N/A |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.08M | N/A |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $10.01M | N/A |
| Ainos, Inc. (AIMD)vs › | $9.79M | N/A |
| Satellos Bioscience Inc. (MSLE)vs › | $10.52M | N/A |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.75M | N/A |
| Cerenome, Inc. (CNSY)vs › | $10.81M | N/A |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.32M | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
